カテゴリー： 世界, 医療/バイオ, Inkwood Research

男性不妊症のグローバル市場2023〜2032

【英語タイトル】GLOBAL MALE INFERTILITY MARKET FORECAST 2023-2032

Inkwood Researchが出版した調査資料（INK23JUL011）・商品コード：INK23JUL011
・発行会社（調査会社）：Inkwood Research
・発行日：2023年5月20日
・ページ数：238
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Inkwood Research社の本調査レポートによると、男性不妊症の世界市場が2023年〜2032年にかけて年平均4.53%で拡大すると見込まれています。本書は、男性不妊症の世界市場について調査し、市場状況や今後の展望を整理しています。調査範囲・調査手法、エグゼクティブサマリー、市場動向、主要分析、検査別（DNA断片化技術、酸化ストレス分析、顕微鏡検査、精子凝集反応、その他）分析、治療別（生殖補助医療・手術、治療薬）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ、アメリカ、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、日本、インド、韓国、ベトナム、その他地域）分析、競争状況などの項目が掲載されています。また、市場参入企業として、ADVACARE PHARMA USA、ANDROLOGY SOLUTIONS、AYTU BIOPHARMA、BAYER GROUP、CAERUS BIOTECH、CINNAGEN CO、EMD SERONO INC (MERCK SERONO)などの情報が含まれています。
・調査範囲・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・世界の男性不妊症市場規模：検査別
- DNA断片化技術における市場規模
- 酸化ストレス分析における市場規模
- 顕微鏡検査における市場規模
- 精子凝集反応における市場規模
- その他検査における市場規模
・世界の男性不妊症市場規模：治療別
- 生殖補助医療・手術における市場規模
- 治療薬における市場規模
・世界の男性不妊症市場規模：地域別
- 北米の男性不妊症市場規模
- ヨーロッパの男性不妊症市場規模
- アジア太平洋の男性不妊症市場規模
- 中南米の男性不妊症市場規模
- 中東/アフリカの男性不妊症市場規模
- アメリカの男性不妊症市場規模
- カナダの男性不妊症市場規模
- イギリスの男性不妊症市場規模
- ドイツの男性不妊症市場規模
- フランスの男性不妊症市場規模
- イタリアの男性不妊症市場規模
- スペインの男性不妊症市場規模
- 中国の男性不妊症市場規模
- 日本の男性不妊症市場規模
- インドの男性不妊症市場規模
- 韓国の男性不妊症市場規模
- ベトナムの男性不妊症市場規模
- その他地域の男性不妊症市場規模
・競争状況

KEY FINDINGS
The global male infertility market is predicted to record a 4.53% CAGR during the forecast period from 2023 to 2032. Surging incidences of infertility, adoption of assisted reproductive technologies, and technological advancements boost the market growth globally.

MARKET INSIGHTS
Several significant factors drive the growth of the global male infertility market, including issues with sperm production or delivery, such as low sperm count, abnormal sperm function, or blockages, commonly cause male infertility. Additionally, illnesses, chronic health problems, injuries, lifestyle choices, and other factors contribute to male infertility.
The surging incidence of infertility and the adoption of assisted reproductive technologies (ART) are crucial in addressing male infertility challenges. Assisted reproductive technologies provide a viable solution for men facing infertility issues, offering higher success rates compared to medications. The widespread adoption of these technologies has increased pregnancy possibilities for infertile couples worldwide, contributing to the growth of the male infertility market.

REGIONAL INSIGHTS
The global male infertility market evaluation comprises a study of Asia-Pacific, North America, Europe, and Rest of World. Europe is estimated to dominate in terms of market share owing to the increased adoption of affordable therapies and devices, assisted reproductive technologies, and reimbursement coverage.

COMPETITIVE INSIGHTS
The global male infertility market is characterized by intense competition due to the presence of numerous companies. These companies strive to develop innovative products for infertility treatment, and regional players compete with established brands. Market players focus on conducting clinical trials, developing new products, and launching novel solutions to gain a competitive edge.
Leading market players include CinnaGen Co, Endo International PLC, Caerus Biotech, EMD Serono Inc (Merck Serono), etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
2.5.2. PREVALENCE OF DIABETES AND CANCER
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING INFERTILITY INCIDENCES
3.1.2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
3.2.1. HIGH TREATMENT COSTS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TEST TYPE
5.1. DNA FRAGMENTATION TECHNIQUE
5.2. OXIDATIVE STRESS ANALYSIS
5.3. MICROSCOPIC EXAMINATION
5.4. SPERM AGGLUTINATION
5.5. COMPUTER-ASSISTED SEMEN ANALYSIS
5.6. SPERM PENETRATION ASSAY
5.7. OTHER TEST TYPES
6. MARKET BY TREATMENT
6.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
6.2. MEDICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. NORTH AMERICA MALE INFERTILITY MARKET DRIVERS
7.1.3. NORTH AMERICA MALE INFERTILITY MARKET CHALLENGES
7.1.4. KEY PLAYERS IN NORTH AMERICA MALE INFERTILITY MARKET
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.1.1. UNITED STATES MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.1.5.2. CANADA
7.1.5.2.1. CANADA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2. EUROPE
7.2.1. MARKET SIZE & ESTIMATES
7.2.2. EUROPE MALE INFERTILITY MARKET DRIVERS
7.2.3. EUROPE MALE INFERTILITY MARKET CHALLENGES
7.2.4. KEY PLAYERS IN EUROPE MALE INFERTILITY MARKET
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.1.1. UNITED KINGDOM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.2. GERMANY
7.2.5.2.1. GERMANY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.4. ITALY
7.2.5.4.1. ITALY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.5. SPAIN
7.2.5.5.1. SPAIN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.6. BELGIUM
7.2.5.6.1. BELGIUM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.7. POLAND
7.2.5.7.1. POLAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.2.5.8. REST OF EUROPE
7.2.5.8.1. REST OF EUROPE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3. ASIA-PACIFIC
7.3.1. MARKET SIZE & ESTIMATES
7.3.2. ASIA-PACIFIC MALE INFERTILITY MARKET DRIVERS
7.3.3. ASIA-PACIFIC MALE INFERTILITY MARKET CHALLENGES
7.3.4. KEY PLAYERS IN ASIA-PACIFIC MALE INFERTILITY MARKET
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.3. INDIA
7.3.5.3.1. INDIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.4. SOUTH KOREA
7.3.5.4.1. SOUTH KOREA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.5. INDONESIA
7.3.5.5.1. INDONESIA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.6. THAILAND
7.3.5.6.1. THAILAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.7. VIETNAM
7.3.5.7.1. VIETNAM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.8. AUSTRALIA & NEW ZEALAND
7.3.5.8.1. AUSTRALIA & NEW ZEALAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.3.5.9. REST OF ASIA-PACIFIC
7.3.5.9.1. REST OF ASIA-PACIFIC MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.4. REST OF WORLD
7.4.1. MARKET SIZE & ESTIMATES
7.4.2. REST OF WORLD MALE INFERTILITY MARKET DRIVERS
7.4.3. REST OF WORLD MALE INFERTILITY MARKET CHALLENGES
7.4.4. KEY PLAYERS IN REST OF WORLD MALE INFERTILITY MARKET
7.4.5. REGIONAL ANALYSIS
7.4.5.1. LATIN AMERICA
7.4.5.1.1. LATIN AMERICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
7.4.5.2. MIDDLE EAST & AFRICA
7.4.5.2.1. MIDDLE EAST & AFRICA MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS
8.2. COMPANY PROFILES
8.2.1. ADVACARE PHARMA USA
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCTS / SERVICES LIST
8.2.2. ANDROLOGY SOLUTIONS
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCTS / SERVICES LIST
8.2.3. AYTU BIOPHARMA
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCTS / SERVICES LIST
8.2.3.3. STRENGTHS & CHALLENGES
8.2.4. BAYER GROUP
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCTS / SERVICES LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. CAERUS BIOTECH
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCTS / SERVICES LIST
8.2.6. CINNAGEN CO
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCTS / SERVICES LIST
8.2.6.3. STRENGTHS & CHALLENGES
8.2.7. EMD SERONO INC (MERCK SERONO)
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCTS / SERVICES LIST
8.2.7.3. STRENGTHS & CHALLENGES
8.2.8. ENDO INTERNATIONAL PLC
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCTS / SERVICES LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. HALOTECH DNA
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCTS / SERVICES LIST
8.2.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCTS / SERVICES LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. SANOFI
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCTS / SERVICES LIST
8.2.11.3. STRENGTHS & CHALLENGES
8.2.12. SCSA DIAGNOSTICS
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCTS / SERVICES LIST
8.2.13. THERAMEX
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCTS / SERVICES LIST
8.2.14. VITROLIFE
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCTS / SERVICES LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCTS / SERVICES LIST
8.2.15.3. STRENGTHS & CHALLENGES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – MALE INFERTILITY
TABLE 2: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL DNA FRAGMENTATION TECHNIQUE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL OXIDATIVE STRESS ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL MICROSCOPIC EXAMINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL SPERM AGGLUTINATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL COMPUTER-ASSISTED SEMEN ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL SPERM PENETRATION ASSAY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL OTHER TEST TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL OTHER TEST TYPES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL MEDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL MEDICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL MALE INFERTILITY MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: NORTH AMERICA MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: KEY PLAYERS OPERATING IN NORTH AMERICA MALE INFERTILITY MARKET
TABLE 29: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: KEY PLAYERS OPERATING IN EUROPE MALE INFERTILITY MARKET
TABLE 32: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: KEY PLAYERS OPERATING IN ASIA-PACIFIC MALE INFERTILITY MARKET
TABLE 35: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: REST OF WORLD MALE INFERTILITY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: KEY PLAYERS OPERATING IN REST OF WORLD MALE INFERTILITY MARKET
TABLE 38: LIST OF MERGERS & ACQUISITIONS
TABLE 39: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 40: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 41: LIST OF BUSINESS EXPANSIONS


★調査レポート[男性不妊症のグローバル市場2023〜2032] (コード：INK23JUL011)販売に関する免責事項を必ずご確認ください。
★調査レポート[男性不妊症のグローバル市場2023〜2032]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 眼瞼形成術のグローバル市場2024〜2032
  • アジア太平洋の病院用ガウン市場2023-2032
  • 歯科用滅菌のグローバル市場2023〜2032
  • 世界の病院用ガウン市場2023-2032
  • アンチエイジングサービス・機器のグローバル市場2024〜2032
  • アジア太平洋のインスリンパッチポンプ市場2023-2032
  • 世界のインスリンパッチポンプ市場2023-2032
  • 煙感知器のグローバル市場2023〜2032
  • 歯科用滅菌のアジア太平洋市場2023〜2032

    • ◆H&Iグローバルリサーチのお客様（例）◆